Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-06-03
1997-06-24
Hutzell, Paula K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 16, 530328, 530868, A61K 3808, C07K 706
Patent
active
056417462
ABSTRACT:
A method of inducing symptoms similar to those in AIDS-infected individuals, particularly neurological deficit, wherein peptide T, VIP or gp120 or a derivative or peptide analog thereof is intrathecally administered to non-human mammals.
REFERENCES:
Yaksh, T.L., et al., Science 192 (1976) 1357-1358.
Hill, J.M., et al., Brain Res., 603(2) (1993) 222-233.
Brenneman et al. Nature 335 (1988) 639-642.
Brenneman et al., Drug Dev. Res. 15 (1988) 361-369.
Muller et al., Eur. J. Pharm. 226 (1992) 209-214.
Glowa et al., Brain Res 570 (1992) 49-53.
Pert et al., PNAS, 83 (1986) 9254-9258.
Bridge, T.P., et al., Lancet II (1989) 226-227.
Steinman, et al., (abstr.) IXth International Conference on AIDS, Berlin (1993).
Dreyer, E.B., et al., Science, vol. 248, (1990) 364-367.
Gibbons, A., Science, "Is AIDS Dementia Due to Increases in Calcium?" (Apr. 20, 1990) 303.
Dawson, V.L. et al., (abstr.) Society for Neuroscience, vol. 18 (1992) 321.1.
Hutzell Paula K.
Prickril Benet
Rutgers State University of New Jersey
LandOfFree
Animal model for AIDS does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Animal model for AIDS, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Animal model for AIDS will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-149119